Skip to main content
Premium Trial:

Request an Annual Quote

Jerome Konecsni, Randal Johnston, William Haseltine, Kreatech Biotechnology, Ambion, and More

Premium

People in the News

Jerome Konecsni has been appointed as president and chief executive officer of Genome Prairie, the Calgary, Canada-based company said earlier this month. He succeeds Randal Johnston. Previously, Konecsni was vice president of corporate development at the Saskatchewan biotech firm Bioriginal. He holds BA, BEd, and MA degrees from the University of Saskatchewan.


William Haseltine has become a senior life sciences advisor of CMEA Ventures, the San Francisco-based venture capital firm said last week. He is the former chief executive of Human Genome Sciences. Haseltine holds a doctorate in biophysics from Harvard University.

New Product Watch

Kreatech Biotechnology this week launched its RNA ampULSe Amplification and Labeling Kits for DNA microarray applications.

The kit combines technology obtained from an agreement with Ambion for their MessageAmp II aRNA amplification system with Kreatech's Universal Linkage system labeling technology.

The company claims the kit will provide users with all the reagents necessary to go from total RNA samples to microarrays.


Agilent Technologies last week launched its Mouse Genome CGH Microarray 44A, which the company claims is the first mouse array specifically tailored for comparative genomic hybridization experiments.

According to Agilent, the Mouse Genome CGH array consists of 43,000, 60-mer oligo probes that provide coverage for the most commonly studied regions and cancer-related genes. Agilent said that it would be adding more organism-specific CGH arrays in the future.


SuperArray Bioscience last week launched GEArray Express, an array platform that is suitable for profiling the expression of focused sets of genes, according to the firm.

SuperArray also said that GEArray Express is capable up to 32 arrays a day and that "nearly 100 samples can be processed in 3 days at a cost of less than $100 per sample."


BioSoft International launched the fourth version of its Array Designer this week.

Array Designer is a desktop software tool that enables users to design oligos for their SNP and expression experiments, BioSoft said.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.